Revolutionize the delivery of RNA & protein
We create unique therapeutic bacteria for unmet patient needs. Our therapeutic focus includes pancreatic cancer and other solid tumors, as well as genetic disorders. Industry collaboration is an important pillar of our strategy.
Redbiotec News
Analysis of Redbiotec by In Vivo (Informa Pharma Intelligence)
Redbiotec Pivots Toward HSV-2 Therapies And Therapeutic Bacteria Redbiotec has reached a new inflection point as it progresses two key [...]
Redbiotec Signs Collaboration Agreement with Large-Cap Pharma to Develop Targeted Living Medicines
Redbiotec AG has entered into a research collaboration and exclusive option agreement with a large-cap pharmaceutical company. The collaboration will [...]
Swiss Nordic Bio Conference
Date: Feb 6, 2020 Location: Zürich We will attend this year's Swiss Nordic Bio Conference, and look forward to sharing [...]
Outlook 2020
We thank you for your trust and support in 2019 and we wish you all the best in the forthcoming [...]